A case study authored by
Gregory L. Moneta, MD

Professor of Surgery
Oregon Health Sciences University
Portland, Oregon

The Faculty Disclosure Policy of the Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the activity. It is required by the ACCME that any mention of unlabeled use of a commercial product or device or an investigational use not yet approved by the FDA be disclosed to participants.

Gregory L. Moneta, MD, has had no financial arrangements or affiliations with commercial or equipment companies within the last 3 years.

A case study authored by
David P. Fivenson, MD
Director, Wound Care Immunodermatology
and Clinical Research Services
Henry Ford Health System
Detroit, Michigan

Lubomira Scherschun, MD
Dermatology Research Fellow
Henry Ford Health System
Detroit, Michigan

Michele M. Choucair, MD
Resident, Dermatology
Henry Ford Health System
Detroit, Michigan

The Faculty Disclosure Policy of the Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the activity. It is required by the ACCME that any mention of unlabeled use of a commercial product or device or an investigational use not yet approved by the FDA be disclosed to participants.

David P. Fivenson, MD, had received grant/research support from, served as a consultant to, or participated on the speakers’ bureau of Advanced Tissue Sciences, Inc., Allergan, Inc., Novartis Pharmaceuticals Corporation, Organogenesis, Inc., Ortho-McNeil Pharmaceutical, and Smith & Nephew United, Inc.